ATC Group: N05AN Lithium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05AN in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05A Antipsychotics
4 N05AN Lithium

Group N05AN contents

Code Title
N05AN01 Lithium

Active ingredients in N05AN

Active Ingredient

Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism.

Related product monographs

Document Type Information Source  
 CAMCOLIT Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PRIADEL Prolonged-release tablet MPI, EU: SmPC Health Products Regulatory Authority (IE)